The FDA Group is a global leader in life science consulting, staff augmentation, recruitment, remediation, auditing, and other quality system services.
Why is The FDA Group in business? The FDA Group is in business to enhance the quality of people’s lives. Whether it is our clients, employees, contractors, vendors, communities, or the patients who receive the products we touch, our purpose lies in discovering meaningful ways to apply our...
The FDA Group is dedicated to ensuring our auditors are always ahead in the ever-evolving regulatory landscape. OurInsider Newsletterprovides bi-weekly updates on the latest FDA and related regulatory news, from new guidelines to enforcement actions. ...
Learn how The FDA Group deployed its staff augmentation model to support a multinational pharmaceutical company's QMS remediation efforts. This project principally included deviation and CAPA backlog activities, significant corrective and preventive remediation throughout the quality system, and extended supp...
E.U. (non-citizen) Other The FDA Group needs the contact information you provide to contact you about relevant offers and services. You may unsubscribe at anytime. For information on our privacy practices and how to unsubscribe, review ourPrivacy Policy....
The Functional Service Program (FSP) is a bundled engagement option that consolidates your externally-sourced projects through a single vendor in The FDA Group. By streamlining vendor management, our FSP eliminates inefficiency, reduces budget overruns, and provides high-quality services from the indust...
The Functional Service Program (FSP) is a bundled engagement option that consolidates your externally-sourced projects through a single vendor in The FDA Group. By streamlining vendor management, our FSP eliminates inefficiency, reduces budget overruns, and provides high-quality services from the indust...
The FDA Group recommends 1. Hold a cross-functional team meeting ahead of the project.A few major goals of this session should be to (1) understand how the new system will affect each department, (2) provide an opportunity for departments to exchange information about their processes, and (...
andrecycling resources, therefore keeping them in circulation well into the future. We constantly strive to find better ways of doing things to grow business, enhance sustainability and enrich people’s lives. As a future-driven group, we are committed to creating lasting value for the environment...
Previously, the drug was used in veterinary medicine; however, today it is being developed for the treatment of scleroderma and has received orphan drug designation from FDA. Halofuginone is an inhibitor that inhibits the development of T FDCA & Next Generation PolyesterFrom Plant Based materials ...